BACKGROUND: Vascular endothelium undergoes apoptosis when exposed to reactive oxygen species (ROS), including hydrogen peroxide and superoxide radicals. ROS are believed to be the cause of damage to small vessels during ischemia-reperfusion injury and of arterial damage during atherosclerosis. Hydrogen peroxide-induced apoptosis is mediated through the inhibition of Bcl-xl activity and caspase-3 and caspase-9 activation. The BH4 domain of the Bcl-2 family members is responsible for their antiapoptotic activity. The BH4 domains of Bcl-2 and Bcl-xl inhibit cytochrome c release and the loss of mitochondrial membrane potential. METHODS AND RESULTS: The purpose of this project was to study the antiapoptotic effect of cell-permeant derivative of Bcl-2 (BH4 peptide) on endothelial cells exposed to stress conditions. BH4 peptide was conjugated to the cell-permeable peptide TAT and was applied to endothelial cells under conditions of serum starvation and hydrogen peroxide treatment. TAT-BH4 reduced caspase-3 activity and prevented apoptotic cell death. CONCLUSION: Our results indicate that TAT-BH4 peptide can protect endothelial cells from ROS-induced apoptosis. Copyright 2004 S. Karger AG, Basel
BACKGROUND: Vascular endothelium undergoes apoptosis when exposed to reactive oxygen species (ROS), including hydrogen peroxide and superoxide radicals. ROS are believed to be the cause of damage to small vessels during ischemia-reperfusion injury and of arterial damage during atherosclerosis. Hydrogen peroxide-induced apoptosis is mediated through the inhibition of Bcl-xl activity and caspase-3 and caspase-9 activation. The BH4 domain of the Bcl-2 family members is responsible for their antiapoptotic activity. The BH4 domains of Bcl-2 and Bcl-xl inhibit cytochrome c release and the loss of mitochondrial membrane potential. METHODS AND RESULTS: The purpose of this project was to study the antiapoptotic effect of cell-permeant derivative of Bcl-2 (BH4 peptide) on endothelial cells exposed to stress conditions. BH4 peptide was conjugated to the cell-permeable peptide TAT and was applied to endothelial cells under conditions of serum starvation and hydrogen peroxide treatment. TAT-BH4 reduced caspase-3 activity and prevented apoptotic cell death. CONCLUSION: Our results indicate that TAT-BH4 peptide can protect endothelial cells from ROS-induced apoptosis. Copyright 2004 S. Karger AG, Basel
Authors: Akiko Iwata; Vicki Morgan-Stevenson; Barbara Schwartz; Li Liu; Joan Tupper; Xiaodong Zhu; John Harlan; Robert Winn Journal: PLoS One Date: 2010-02-08 Impact factor: 3.240
Authors: Yi-Ping Rong; Geert Bultynck; Ademuyiwa S Aromolaran; Fei Zhong; Jan B Parys; Humbert De Smedt; Gregory A Mignery; H Llewelyn Roderick; Martin D Bootman; Clark W Distelhorst Journal: Proc Natl Acad Sci U S A Date: 2009-08-17 Impact factor: 11.205
Authors: Jonathan E McDunn; Jared T Muenzer; Benjamin Dunne; Anthony Zhou; Kevin Yuan; Andrew Hoekzema; Carolyn Hilliard; Katherine C Chang; Christopher G Davis; Jacquelyn McDonough; Clayton Hunt; Perry Grigsby; David Piwnica-Worms; Richard S Hotchkiss Journal: Biochem Biophys Res Commun Date: 2009-03-19 Impact factor: 3.575
Authors: Tim Vervliet; Irma Lemmens; Elien Vandermarliere; Elke Decrock; Hristina Ivanova; Giovanni Monaco; Vincenzo Sorrentino; Nael Nadif Kasri; Ludwig Missiaen; Lennart Martens; Humbert De Smedt; Luc Leybaert; Jan B Parys; Jan Tavernier; Geert Bultynck Journal: Sci Rep Date: 2015-04-15 Impact factor: 4.379
Authors: Giovanni Monaco; Elke Decrock; Koen Nuyts; Larry E Wagner; Tomas Luyten; Sergei V Strelkov; Ludwig Missiaen; Wim M De Borggraeve; Luc Leybaert; David I Yule; Humbert De Smedt; Jan B Parys; Geert Bultynck Journal: PLoS One Date: 2013-08-30 Impact factor: 3.240
Authors: Tim Vervliet; Julia V Gerasimenko; Pawel E Ferdek; Monika A Jakubowska; Ole H Petersen; Oleg V Gerasimenko; Geert Bultynck Journal: Cell Death Discov Date: 2018-05-10